PUMA BIOTECHNOLOGY, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2020
Total Assets: $244.2M
Liabilities Breakdown FY2020
Total Liabilities: $250.2M
Asset Breakdown
Total Assets: $244.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $85.3M | 34.9% |
| Accounts Receivable | $25.5M | 10.5% |
| Inventory | $3.5M | 1.4% |
| Property, Plant & Equipment | $2.5M | 1.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $74.1M | 30.4% |
| Other Assets | $53.3M | 21.8% |
Liabilities Breakdown
Total Liabilities: $250.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $12.1M | 4.8% |
| Long-Term Debt | $84.0M | 33.6% |
| Other Liabilities | $154.1M | 61.6% |